Joaquin Duato compensation by year
JOHNSON & JOHNSON Summary Compensation Table · all 10 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salary | $875,000 | $897,254 | $934,046 | $969,615 | $1,021,538 | $1,030,000 | $1,490,962 | $1,584,615 | $1,600,000 | $1,600,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Stock awards | $3,198,483 | $11,483,016 | $4,275,951 | $4,622,787 | $6,798,093 | $7,001,281 | $5,940,829 | $11,182,143 | $10,787,159 | $15,028,948 |
| Option awards | $1,260,002 | $1,650,003 | $1,892,999 | $1,974,005 | $2,193,000 | $2,393,998 | $2,318,959 | $4,796,990 | $4,919,991 | $5,927,995 |
| Non-equity incentive | $2,158,006 | $1,928,262 | $2,010,088 | $2,295,437 | $1,820,403 | $2,319,450 | $3,079,750 | $4,378,500 | $3,981,050 | $4,298,700 |
| Pension and deferred compensation | $2,535,760 | $3,329,047 | $79,000 | $3,469,000 | $3,746,000 | $875,767 | $0 | $6,213,000 | $2,694,000 | $5,301,237 |
| All other | $77,278 | $71,726 | $91,876 | $88,458 | $45,969 | $184,796 | $268,987 | $241,992 | $320,160 | $601,231 |
| Total | $10,104,529 | $19,359,308 | $9,283,960 | $13,419,302 | $15,625,003 | $13,805,292 | $13,099,487 | $28,397,240 | $24,302,360 | $32,758,111 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: JOHNSON & JOHNSON DEF 14A filed March 11, 2026, accession 0000200406-26-000063, and prior-year filings. Open the filing on EDGAR.
How this page was built: the JOHNSON & JOHNSON filed document, accession 0000200406-26-000063. Every figure is read from that document and cited to the page and table it appears in. Filed March 11, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 131,652 | $27,334,905 | — |
| RSU | 83,906 | $17,421,403 | — |
| RSU | 73,053 | $15,167,994 | — |
| RSU | 13,513 | $2,805,704 | — |
| RSU | 7,364 | $1,528,987 | — |
| RSU | 3,469 | $720,268 | — |
| Option | 133,516 | — | $151.41 |
| Option | 110,868 | — | $131.94 |
| Option | 118,544 | — | $157.92 |
| Option | 219,020 | — | $156.15 |
| Option | 123,291 | — | $115.67 |
| Option | 105,307 | — | $129.51 |
Per the Outstanding Equity Awards at Fiscal Year-End table in JOHNSON & JOHNSON's FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.
Insider transactions since the last proxy
6 Form 4 lines since the FY2025 proxy (filed March 11, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion derivative | — | 123,291 | $0.00 | 0 |
| 2026-08-13 | Sale | — | 102,315 | $261.00 | 275,967 |
| 2026-08-13 | Exercise or conversion | — | 123,291 | $115.67 | 399,258 |
| 2026-08-13 | Sale | — | 20,976 | $262.00 | 378,282 |
| 2026-08-05 | Sale | — | 41,957 | $258.06 | 282,490 |
| 2026-08-05 | Sale | — | 6,523 | $258.74 | 275,967 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
JOHNSON & JOHNSON’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joaquin Duato · this page | Chairman/CEO | $32,758,111 |
| Joseph Wolk | EVP, CFO | $14,405,442 |
| Jennifer Taubert | EVP, WWC Innovative Medicine | $14,030,063 |
| John Reed | EVP, Innovative Medicine, R&D | $12,214,062 |
| Tim Schmid | EVP, WWC, MedTech | $9,336,765 |
Board service
JOHNSON & JOHNSON board · FY2021–FY2025How this board is paid
Company policy: JOHNSON & JOHNSON pays directors a $125,000 cash retainer and $220,000 in Deferred Share Units (DSUs). As stated in JOHNSON & JOHNSON's FY2025 proxy.
Committees
Finance
The full JOHNSON & JOHNSON compensation record
free company briefThis page is one person within JOHNSON & JOHNSON's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the JOHNSON & JOHNSON proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order JOHNSON & JOHNSON's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are JOHNSON & JOHNSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order JNJ
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.